Foluso Fakorede, MD
Cardiovascular Disease
Foluso A. Fakorede, MD, received his medical degree from UMDNJ-Robert Wood Johnson Medical School in Camden, NJ. He completed his internship and residency at New York Presbyterian Weill Cornell Hospital and returned to New Jersey for a fellowship in cardiology, interventional cardiology, and endovascular intervention at Cooper University Hospital in Camden. Today, he is an expert at preventive cardiovascular management, women’s heart health, and catheter-based procedural focus in coronary atherosclerosis disease (CAD) and peripheral atherosclerosis disease. He has advanced technical skills in preventing amputations, and in 2015 he opened Cardiovascular Solutions of Central Mississippi in Cleveland, located in the Mississippi Delta. Dr Fakorede is a national advocate for ending health disparities in underserved communities.
Related Videos
Video
What is PAD with Dr. Foluso Fakorede
Foluso Fakorede, MD, explains what is PAD, peripheral arterial disease and how it effects more people than most are aware of.
Video
A message to healthcare providers about PAD and PVD
Foluso Fakorede, MD believes it is important to screen patients with at risk factors, such as heart disease, tobacco use, high blood pressure, checking the feet etc.
Video
My experience with Symphony Suite with Dr. Foluso Fakorede
Foluso Fakorede, MD, shares his thoughts on Symphony Suite and how it has benefited his practice and his community.
Video
Foluso Fakorede, MD, explains that is important to take precautions and preventative measures as certain symptoms of PAD could be contributed to 'old age' but could lead to something much more serious.
Video
September is peripheral arterial disease (PAD) awareness month
Foluso Fakorede, MD, explains that PAD is the most prevalent, chronic, deadly disease that most Americans have never heard about, while trying to spread awareness.
Video
Peripheral arterial disease (PAD) awareness message to America
Foluso Fakorede, MD sends a message to America for PAD awareness, fear it like cancer. PAD effects 20 million people.
